Our Clients

OHE's worldwide clientele encompasses the public, private and charity sectorsOHE Consulting's diverse clientele includes government agencies, international organisations and foundations, national foundations and think tanks, health charities and non-profit groups, the life sciences industries, trade associations and academia.

Selected Clients

  • ABPI
  • Alzheimer's Research Trust
  • Amgen Inc.
  • Association of British Healthcare Industries
  • AstraZeneca
  • Bill & Melinda Gates Foundation
  • British Pharma Group
  • Cabinet Office (UK)
  • The Cord Blood Charity
  • Department of Health (England)
  • EFPIA
  • Eisai Ltd
  • Eli Lilly and Company
  • European Commission
  • German Federal Ministry of Health
  • GlaxoSmithKline
  • IFPMA
  • International AIDS Vaccine Initiative
  • International Public Private Partnership for Health
  • Merck Sharp & Dohme
  • Medical Research Council
  • Novartis
  • OECD
  • Pfizer
  • Roche
  • Rockefeller Foundation
  • Sanofi-Synthelabo
  • VFA (Germany)
  • Vodafone
  • Wellcome Trust
  • World Bank
  • World Health Organisation

What they say

"OHE delivered a very high quality piece of work. I was impressed with their analytical capability and collaborative working style."
Pricing and Market Access Director at AstraZeneca

"Thank you for doing an excellent job for EFPIA. Your informative and thorough work on 'The Many Faces of Innovation' report has made a significant contribution at European Policy level."
Member of the EFPIA Economic and Social Policy Committee

"OHE has helped us to frame the economics of biosimilars into its right proportions as well as identifying what payers need to manage biotechnology products with biosimilars differently from chemical products with generics."
Director of International Health Economics & Reimbursement at Amgen